Where can FOXO4-DRI be purchased for laboratory research?

FOXO4-DRI can be ordered directly from this product page. Real Peptides is a US chemical supplier stocking research-use-only compounds, with inventory held at facilities in Florida and California. Orders are placed online and fulfilled from domestic stock, so no import brokerage or overseas transit is involved for research buyers located in the United States.

Is FOXO4-DRI for sale in a 10mg size?

Yes. This listing covers FOXO4-DRI supplied as a 10mg lyophilized multi-dose vial. The quantity shown on the page is the format offered for this compound, and the number of vials per order can be adjusted using the quantity selector before checkout. Each vial ships sealed with lot identification that matches the published certificate.

How is FOXO4-DRI priced?

Pricing is shown live on this product page and reflects the 10mg vial size listed, current lot availability, and the independent laboratory testing performed on each batch. Because figures change with stock and testing cycles, the amount displayed at checkout is always the accurate one. Multi-vial and pack options may reduce the per-vial figure.

Is a certificate of analysis published for FOXO4-DRI?

Yes. Every batch is submitted to an independent third-party laboratory, and the certificate of analysis for the exact lot is published in the lab results section of the site. Researchers can review identity, purity, and analytical method data for the current lot before purchasing, and the lot number on the vial corresponds to that document.

What research applications is FOXO4-DRI used for?

FOXO4-DRI is studied in vitro and in preclinical animal models for its disruption of the FOXO4–p53 interaction. Reported uses include senescent-cell clearance assays, SASP marker profiling, cellular stress and DNA-damage response work, and broader longevity signaling studies. All applications are laboratory investigations; the compound is not a drug and is not intended for human or animal use.

How quickly does FOXO4-DRI ship, and from where?

Orders are dispatched from US warehouses in Florida and California, typically within 24 hours of the order being processed on a business day. Vials are packed to protect the lyophilized material in transit, and tracking details are issued by email once the shipment leaves the facility. Domestic transit times vary by carrier and destination.

How should FOXO4-DRI be stored on arrival?

Common laboratory practice is to keep lyophilized peptide vials sealed, cold, and shielded from light and moisture until they are prepared for an experiment. Reconstituted material is generally handled under refrigeration and used within a limited window. Each laboratory should follow its own written protocols and any storage guidance shown on the certificate for the lot.

Who is eligible to order FOXO4-DRI?

Purchasers confirm at checkout that they are at least 21 years of age and are acquiring the compound for laboratory research purposes only. No institutional affiliation or professional credential is required to place an order. Real Peptides is a chemical supplier, not a compounding pharmacy, and all products are sold strictly for research use, not for human or animal consumption.

1 / 6

Verified Lab Results

Finished in the USA

Research Use Only

Longevity Peptides

FOXO4-DRI Peptide (10mg) for Laboratory Research

~~$288.00~~$144.00Save 50%

FOXO4-DRI is a synthetic retro-inverso peptide built from D-amino acids and modeled on the FOXO4 sequence, designed to interfere with the FOXO4–p53 interaction. It is used in cell culture and preclinical animal models to investigate senescent-cell clearance, senescence-associated secretory phenotype (SASP) signaling, and longevity-related pathways.

Real Peptides supplies FOXO4-DRI as a lyophilized 10mg multi-dose vial for laboratory use. Identity and purity are verified by an independent analytical laboratory, and the certificate for the current lot is published on the lab results page so it can be reviewed before purchase. Vials ship from US facilities in Florida and California, typically within 24 hours of order processing. This material is sold strictly for research use only and is not for human or animal use.

Size

Quantity

$144.00

Bundle & saveBuild Your PackMix & match your pack. The more you add, the more you save — up to 20% off.

Ships within 24 hours
Free standard shipping on orders $250+
Lab report included

FOXO4-DRI · 10mg

$144.00$288.00

Recommended with this order

Frequently paired with this compound by other researchers.

50% off

SS-31 (Elamipretide)~~$57.60~~$28.80

10mg

50% off

NAD+~~$120.00~~$60.00

500mg

50% off

Epithalon (Epitalon)~~$48.00~~$24.00

10mg

For Research Use Only. Not for human consumption or therapeutic treatment.

99% Pure | Multi Dose | Finished in the USA

FOXO4-DRI is a synthetic peptide designed to disrupt the interaction between FOXO4 and p53, prompting targeted clearance of senescent cells in cell culture and animal models. Researchers use FOXO4-DRI to study cellular aging, senescence-associated secretory phenotype (SASP) modulation, and longevity signaling. Each 10 mg vial is and tested to ≥99% purity, with endotoxin <0.1 EU/mg—ideal for your peptide-driven aging research.

What Is FOXO4-DRI?

FOXO4-DRI is a “designed-retro-inverso” peptide that mimics the FOXO4 protein’s binding region in reverse sequence and D-amino-acid form. This design enables it to enter cells and competitively displace FOXO4 from p53, selectively driving senescent cells into programmed cell death. It’s used in preclinical aging and tissue-regeneration models to study the impact of senescent-cell removal on tissue function.

Why Choose FOXO4-DRI?

Researchers choose FOXO4-DRI for its unmatched ability to target senescent cells without harming normal proliferating cells. Its retro-inverso design delivers enhanced stability in culture and in vivo, while rigorous purity testing ensures reproducible results. FOXO4-DRI provides a precise, scalable approach for labs exploring cellular aging, regenerative medicine, and cell-stress response protocols.

What Sets FOXO4-DRI Apart?

Unlike broad-spectrum senolytic compounds, FOXO4-DRI offers molecular specificity by disrupting a single protein–protein interaction (FOXO4:p53) to induce apoptosis only in senescent cells. Its D-amino-acid retro-inverso configuration grants exceptional resistance to proteolytic degradation, ensuring consistent activity throughout your experiments. FOXO4-DRI is the go-to peptide for clean, targeted senescence research.

Longevity Peptides compounds